カテゴリー： Transparency Market Research, 世界, 医療/バイオ

がん生検の世界市場2023～2031：製品別、種類別

◆英語タイトル：Cancer Biopsy Market (Product: Platforms & Instruments, Kits & Reagents, and Services; Type: Tissue Biopsies, Liquid Biopsies, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Transparency Market Researchが発行した調査報告書（TMR23JUL042）◆商品コード：TMR23JUL042
◆発行会社（リサーチ会社）：Transparency Market Research
◆発行日：2023年5月
◆ページ数：190
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD5,795 ⇒換算￥869,250見積依頼/購入/質問フォーム
Multi User（5名様閲覧）USD8,795 ⇒換算￥1,319,250見積依頼/購入/質問フォーム
Corporate License（法人閲覧）USD11,795 ⇒換算￥1,769,250見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Transparency Market Research社の当調査レポートでは、世界のがん生検市場規模が、2023年の247億ドルから2031年までに620億ドルに拡大し、予測期間中に年平均（CAGR）11.4%で成長すると推測しています。本書は、がん生検の世界市場について詳しく調査し、市場状況及び展望についてまとめています。序論、仮定・調査手法、エグゼクティブサマリー、市場概要、主要インサイト、価格分析、製品別（プラットフォーム・器具、キット・試薬、サービス）分析、種類別（組織生検、液体生検、その他）分析、用途別（乳癌、結腸直腸癌、子宮頸癌、肺癌、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況など、以下の構成で掲載しています。また、市場参入企業として、Abbott Laboratories、Becton, Dickinson and Company、F. Hoffmann-La Roche Ltd.、Hologic, Inc.、Danaher Corporation、Thermo Fisher Scientific, Inc.、Agilent Technologies, Inc.、Illumina, Inc.、Siemens Healthineers、GE Healthcare、Bio-Rad Laboratories, Inc.、Olympus Corporation、QIAGENなどを含んでいます。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・主要インサイト
・価格分析
・世界のがん生検市場規模：製品別
- プラットフォーム・器具の市場規模
- キット・試薬の市場規模
- サービスの市場規模
・世界のがん生検市場規模：種類別
- 組織生検の市場規模
- 液体生検の市場規模
- その他種類の市場規模
・世界のがん生検市場規模：用途別
- 乳癌における市場規模
- 結腸直腸癌における市場規模
- 子宮頸癌における市場規模
- 肺癌における市場規模
- その他用途における市場規模
・世界のがん生検市場規模：地域別
- 北米のがん生検市場規模
- ヨーロッパのがん生検市場規模
- アジア太平洋のがん生検市場規模
- 中南米のがん生検市場規模
- 中東・アフリカのがん生検市場規模
・競争状況

Cancer Biopsy Market – Scope of Report
TMR’s report on the global Cancer Biopsy Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Cancer Biopsy Market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Cancer Biopsy Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the Cancer Biopsy market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the Cancer Biopsy.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the Cancer Biopsy. These serve as valuable tools for existing market players as well as for entities interested in participating in the Cancer Biopsy.

The report delves into the competitive landscape of the Cancer Biopsy. Key players operating in the global Cancer Biopsy Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Cancer Biopsy Market profiled in this report.

Key Questions Answered in Global Cancer Biopsy Market Report
• What is the sales/revenue generated by Cancer Biopsy across all regions during the forecast period?
• What are the opportunities in the Cancer Biopsy?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Cancer Biopsy Market – Research Objectives and Research Approach
The comprehensive report on the global Cancer Biopsy Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Cancer Biopsy Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the Cancer Biopsy.

❖ レポートの目次 ❖

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Cancer Biopsy Market
4. Market Overview
    4.1. Introduction
        4.1.1. Segment Definition
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Cancer Biopsy Market Analysis and Forecast, 2017-2031
        4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
    5.1. Cancer Prevalence & Incidence, by Region
    5.2. Technological Advancements
    5.3. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
    5.4. Reimbursement Scenario by Region/Globally
    5.5. Value Chain Analysis
6. Global Cancer Biopsy Market Analysis and Forecast, by Product
    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Product, 2017-2031
        6.3.1. Platforms & Instruments
        6.3.2. Kits & Reagents
        6.3.3. Services
    6.4. Market Attractiveness Analysis, by Product
7. Global Cancer Biopsy Market Analysis and Forecast, by Type
    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by Type, 2017-2031
        7.3.1. Tissue Biopsies
            7.3.1.1. Needle Biopsies
            7.3.1.2. Surgical Biopsies
        7.3.2. Liquid Biopsies
        7.3.3. Others
    7.4. Market Attractiveness Analysis, by Type
8. Global Cancer Biopsy Market Analysis and Forecast, by Application
    8.1. Introduction & Definition
    8.2. Key Findings/Developments
    8.3. Market Value Forecast, by Application, 2017-2031
        8.3.1. Breast Cancer
        8.3.2. Colorectal Cancer
        8.3.3. Cervical Cancer
        8.3.4. Lung Cancer
        8.3.5. Prostate Cancer
        8.3.6. Skin Cancer
        8.3.7. Blood Cancer
        8.3.8. Kidney Cancer
        8.3.9. Liver Cancer
        8.3.10. Pancreatic Cancer
        8.3.11. Ovarian Cancer
        8.3.12. Others
    8.4. Market Attractiveness Analysis, by Application
9. Global Cancer Biopsy Market Analysis and Forecast, by Region
    9.1. Key Findings
    9.2. Market Value Forecast, by Region, 2017-2031
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America
        9.2.5. Middle East & Africa
    9.3. Market Attractiveness Analysis, by Region
10. North America Cancer Biopsy Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast, by Product, 2017-2031
        10.2.1. Platforms & Instruments
        10.2.2. Kits & Reagents
        10.2.3. Services
    10.3. Market Value Forecast, by Type, 2017-2031
        10.3.1. Tissue Biopsies
            10.3.1.1. Needle Biopsies
            10.3.1.2. Surgical Biopsies
        10.3.2. Liquid Biopsies
        10.3.3. Others
    10.4. Market Value Forecast, by Application, 2017-2031
        10.4.1. Breast Cancer
        10.4.2. Colorectal Cancer
        10.4.3. Cervical Cancer
        10.4.4. Lung Cancer
        10.4.5. Prostate Cancer
        10.4.6. Skin Cancer
        10.4.7. Blood Cancer
        10.4.8. Kidney Cancer
        10.4.9. Liver Cancer
        10.4.10. Pancreatic Cancer
        10.4.11. Ovarian Cancer
        10.4.12. Others
    10.5. Market Value Forecast, by Country, 2017-2031
        10.5.1. U.S.
        10.5.2. Canada
    10.6. Market Attractiveness Analysis
        10.6.1. By Product
        10.6.2. By Type
        10.6.3. By Application
        10.6.4. By Country
11. Europe Cancer Biopsy Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Product, 2017-2031
        11.2.1. Platforms & Instruments
        11.2.2. Kits & Reagents
        11.2.3. Services
    11.3. Market Value Forecast, by Type, 2017-2031
        11.3.1. Tissue Biopsies
            11.3.1.1. Needle Biopsies
            11.3.1.2. Surgical Biopsies
        11.3.2. Liquid Biopsies
        11.3.3. Others
    11.4. Market Value Forecast, by Application, 2017-2031
        11.4.1. Breast Cancer
        11.4.2. Colorectal Cancer
        11.4.3. Cervical Cancer
        11.4.4. Lung Cancer
        11.4.5. Prostate Cancer
        11.4.6. Skin Cancer
        11.4.7. Blood Cancer
        11.4.8. Kidney Cancer
        11.4.9. Liver Cancer
        11.4.10. Pancreatic Cancer
        11.4.11. Ovarian Cancer
        11.4.12. Others
    11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
        11.5.1. Germany
        11.5.2. U.K.
        11.5.3. France
        11.5.4. Italy
        11.5.5. Spain
        11.5.6. Rest of Europe
    11.6. Market Attractiveness Analysis
        11.6.1. By Product
        11.6.2. By Type
        11.6.3. By Application
        11.6.4. By Country/Sub-region
12. Asia Pacific Cancer Biopsy Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Product, 2017-2031
        12.2.1. Instruments
        12.2.2. Kits & Reagents
        12.2.3. Services
    12.3. Market Value Forecast, by Type, 2017-2031
        12.3.1. Tissue Biopsies
            12.3.1.1. Needle Biopsies
            12.3.1.2. Surgical Biopsies
        12.3.2. Liquid Biopsies
        12.3.3. Others
    12.4. Market Value Forecast, by Application, 2017-2031
        12.4.1. Breast Cancer
        12.4.2. Colorectal Cancer
        12.4.3. Cervical Cancer
        12.4.4. Lung Cancer
        12.4.5. Prostate Cancer
        12.4.6. Skin Cancer
        12.4.7. Blood Cancer
        12.4.8. Kidney Cancer
        12.4.9. Liver Cancer
        12.4.10. Pancreatic Cancer
        12.4.11. Ovarian Cancer
        12.4.12. Others
    12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
        12.5.1. China
        12.5.2. Japan
        12.5.3. India
        12.5.4. Australia & New Zealand
        12.5.5. Rest of Asia Pacific
    12.6. Market Attractiveness Analysis
        12.6.1. By Product
        12.6.2. By Type
        12.6.3. By Application
        12.6.4. By Country/Sub-region
13. Latin America Cancer Biopsy Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Product, 2017-2031
        13.2.1. Platforms & Platforms & Instruments
        13.2.2. Kits & Reagents
        13.2.3. Services
    13.3. Market Value Forecast, by Type, 2017-2031
        13.3.1. Tissue Biopsies
            13.3.1.1. Needle Biopsies
            13.3.1.2. Surgical Biopsies
        13.3.2. Liquid Biopsies
        13.3.3. Others
    13.4. Market Value Forecast, by Application, 2017-2031
        13.4.1. Breast Cancer
        13.4.2. Colorectal Cancer
        13.4.3. Cervical Cancer
        13.4.4. Lung Cancer
        13.4.5. Prostate Cancer
        13.4.6. Skin Cancer
        13.4.7. Blood Cancer
        13.4.8. Kidney Cancer
        13.4.9. Liver Cancer
        13.4.10. Pancreatic Cancer
        13.4.11. Ovarian Cancer
        13.4.12. Others
    13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
        13.5.1. Brazil
        13.5.2. Mexico
        13.5.3. Rest of Latin America
    13.6. Market Attractiveness Analysis
        13.6.1. By Product
        13.6.2. By Type
        13.6.3. By Application
        13.6.4. By Country/Sub-region
14. Middle East & Africa Cancer Biopsy Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Product, 2017-2031
        14.2.1. Platforms & Instruments
        14.2.2. Kits & Reagents
        14.2.3. Services
    14.3. Market Value Forecast, by Type, 2017-2031
        14.3.1. Tissue Biopsies
            14.3.1.1. Needle Biopsies
            14.3.1.2. Surgical Biopsies
        14.3.2. Liquid Biopsies
        14.3.3. Others
    14.4. Market Value Forecast, by Application, 2017-2031
        14.4.1. Breast Cancer
        14.4.2. Colorectal Cancer
        14.4.3. Cervical Cancer
        14.4.4. Lung Cancer
        14.4.5. Prostate Cancer
        14.4.6. Skin Cancer
        14.4.7. Blood Cancer
        14.4.8. Kidney Cancer
        14.4.9. Liver Cancer
        14.4.10. Pancreatic Cancer
        14.4.11. Ovarian Cancer
        14.4.12. Others
    14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
        14.5.1. GCC Countries
        14.5.2. South Africa
        14.5.3. Rest of Middle East & Africa
    14.6. Market Attractiveness Analysis
        14.6.1. By Product
        14.6.2. By Type
        14.6.3. By Application
        14.6.4. By Country/Sub-region
15. Competition Landscape
    15.1. Market Player – Competition Matrix (by tier and size of companies)
    15.2. Market Share Analysis, by Company, 2022
    15.3. Company Profiles
        15.3.1. Abbott Laboratories
            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.1.2. Product Portfolio
            15.3.1.3. Financial Overview
            15.3.1.4. SWOT Analysis
            15.3.1.5. Strategic Overview
        15.3.2. Becton, Dickinson and Company
            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.2.2. Product Portfolio
            15.3.2.3. Financial Overview
            15.3.2.4. SWOT Analysis
            15.3.2.5. Strategic Overview
        15.3.3. F. Hoffmann-La Roche Ltd.
            15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.3.2. Product Portfolio
            15.3.3.3. Financial Overview
            15.3.3.4. SWOT Analysis
            15.3.3.5. Strategic Overview
        15.3.4. Hologic, Inc.
            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.4.2. Product Portfolio
            15.3.4.3. Financial Overview
            15.3.4.4. SWOT Analysis
            15.3.4.5. Strategic Overview
        15.3.5. Danaher Corporation
            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.5.2. Product Portfolio
            15.3.5.3. Financial Overview
            15.3.5.4. SWOT Analysis
            15.3.5.5. Strategic Overview
        15.3.6. Thermo Fisher Scientific, Inc.
            15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.6.2. Product Portfolio
            15.3.6.3. Financial Overview
            15.3.6.4. SWOT Analysis
            15.3.6.5. Strategic Overview
        15.3.7. Agilent Technologies, Inc.
            15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.7.2. Product Portfolio
            15.3.7.3. Financial Overview
            15.3.7.4. SWOT Analysis
            15.3.7.5. Strategic Overview
        15.3.8. Illumina, Inc.
            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.8.2. Product Portfolio
            15.3.8.3. Financial Overview
            15.3.8.4. SWOT Analysis
            15.3.8.5. Strategic Overview
        15.3.9. Siemens Healthineers
            15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.9.2. Product Portfolio
            15.3.9.3. Financial Overview
            15.3.9.4. SWOT Analysis
            15.3.9.5. Strategic Overview
        15.3.10. GE Healthcare
            15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.10.2. Product Portfolio
            15.3.10.3. Financial Overview
            15.3.10.4. SWOT Analysis
            15.3.10.5. Strategic Overview
        15.3.11. Bio-Rad Laboratories, Inc.
            15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.11.2. Product Portfolio
            15.3.11.3. Financial Overview
            15.3.11.4. SWOT Analysis
            15.3.11.5. Strategic Overview
        15.3.12. Olympus Corporation
            15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.12.2. Product Portfolio
            15.3.12.3. Financial Overview
            15.3.12.4. SWOT Analysis
            15.3.12.5. Strategic Overview
        15.3.13. QIAGEN
            15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.13.2. Product Portfolio
            15.3.13.3. Financial Overview
            15.3.13.4. SWOT Analysis
            15.3.13.5. Strategic Overview

List of Tables

Table 01: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 02: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031

Table 03: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 04: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031

Table 05: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031

Table 06: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Region, 2017-2031

Table 07: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Country, 2017-2031

Table 08: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 09: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031

Table 10: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 11: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031

Table 12: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031

Table 13: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 14: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 15: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031

Table 16: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 17: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031

Table 18: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031

Table 19: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 20: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 21: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031

Table 22: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 23: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031

Table 24: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031

Table 25: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 26: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 27: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031

Table 28: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 29: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031

Table 30: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031

Table 31: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 32: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 33: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031

Table 34: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 35: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031

Table 36: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ がん生検の世界市場2023～2031：製品別、種類別(Cancer Biopsy Market (Product: Platforms & Instruments, Kits & Reagents, and Services; Type: Tissue Biopsies, Liquid Biopsies, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031)]についてメールでお問い合わせはこちらでお願いします。
グローバルリサーチ調査資料のイメージグローバルリサーチ調査資料のイメージ
◆関連リサーチレポート◆
  • 近接照射療法シードの世界市場2023～2031：放射性シード種類別、用途別
  • がんプロファイリングの世界市場2023～2031：製品別、がん種類別
  • 世界のヒトパピローマウイルスワクチン市場2023-2031：疾患別（子宮頸がん、肛門がん、膣がん、陰茎がん、外陰がん、中咽頭がん、性器いぼ、その他）
  • 前立腺癌低侵襲手術の世界市場2022～2031：手術別
  • HER2検査の世界市場2023～2031：技術別

    • ◆H&Iグローバルリサーチのお客様（例）◆